biologit Media

The FutureVigilance Series continues with a second session on AI in Pharmacovigilance, held on August 29th. This webinar marked the beginning of a deep-dive exploration of how artificial intelligence is transforming drug safety monitoring. Our expert speakers shared valuable insights into the current state of AI in the field. They addressed ethical and regulatory considerations and offered insights into the future of AI-enhanced patient safety.

The FutureVigilance Series kicks off with a session on Process & Change Management, hosted on the Truliant Talks platform. This inaugural webinar, held on June 6th, marked the beginning of a comprehensive exploration into the future of pharmacovigilance. With a focus specifically on the dynamic world of pharmacovigilance, the session focused deeply on how evolving processes and effective change management can shape the future of this industry.

The MedTech regulatory landscape is rapidly evolving and literature review plays a key role in meeting requirements.

In this webinar Nicole Baker (CEO) discusses advances in AI for pharmacovigilance, the regulatory landscape and the biologit MLM-AI solution for literature screening powered by AI.

Across many industries the regulatory landscape for deploying ML systems is still evolving: with many so frameworks and proposals being put forward, how do practitioners make progress?

How can good documentation practices improve quality, reduce risks and ensure compliance? Bruno Ohana presents a case study that applies AboutML principles conducted in collaboration with the Partnership on AI.